Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs Abdominal Cystic Lymphangioma C2930929
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and Abdominal Cystic Lymphangioma for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
Abdominal Cystic Lymphangioma C2930929
A non-cancerous fluid-filled growth developing from lymphatic vessels in the abdomen. Usually found in children. Treatment may involve surgical removal or other interventions.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
Abdominal Cystic Lymphangioma C2930929
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
Abdominal Cystic Lymphangioma C2930929
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
Abdominal Cystic Lymphangioma C2930929
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
Abdominal Cystic Lymphangioma C2930929
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
Abdominal Cystic Lymphangioma C2930929
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
Abdominal Cystic Lymphangioma C2930929
rare-disease
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and abdominal-cystic-lymphangioma-C2930929 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | Abdominal Cystic Lymphangioma C2930929 | Discriminating power |
|---|---|---|---|
| Genital development | An XX infant may have atypical external genitalia after maternal androgen exposure. | Genital development is not the defining feature. | High |
| Abdominal mass | An abdominal mass is not an established defining feature. | A fluid-filled lymphatic growth may appear as an abdominal mass, often in childhood. | High |
| Exposure history | A maternal androgen source may be relevant, but causation needs specialist confirmation. | No established association with maternal androgens is supplied. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
XX infant with atypical genitalia and possible maternal androgen exposure
This pattern aligns with a reproductive endocrine condition rather than a lymphatic cyst.
Moderate
Hormone and sex-development assessment is the main question
Karyotype, hormones, and exposure history require specialist review.
High
No cystic abdominal lymphatic lesion is identified
This makes lymphangioma less likely as the principal explanation.
Moderate
Choose Abdominal Cystic Lymphangioma C2930929 when
Child with a cystic abdominal mass on imaging
Imaging supports evaluation for a lymphatic malformation.
High
Tissue or imaging suggests lymphatic spaces
Such findings favor cystic lymphangioma over a sex-development disorder.
Moderate
Sex development is typical and androgen exposure is not suspected
This lowers support for maternal-androgen 46,XX DSD.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | Abdominal Cystic Lymphangioma C2930929 | Interpretation |
|---|---|---|---|
| Karyotype and endocrine tests | 46,XX with specialist hormone assessment; no universal cutoff is established here. | Sex-chromosome and androgen testing are not primary diagnostic tests. | Abnormal results are findings and do not alone establish the diagnosis. |
| Abdominal ultrasound or MRI | Not expected to define the condition. | May show a multiloculated fluid-filled abdominal lesion. | Imaging can suggest lymphangioma but may require further confirmation. |
| Histopathology | Not typically the main diagnostic test. | Removed tissue may show benign lymphatic vascular spaces. | Pathologic confirmation depends on adequate sampling and review. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Severity may range from mild to severe; long-term outcome is not established here.
- Factors
- Degree of androgen effect, associated conditions, and timing of specialist care.
Abdominal Cystic Lymphangioma C2930929
- Outcome
- Usually benign, but intervention or recurrence may occur; risk is not quantified.
- Factors
- Size, location, symptoms, and completeness of treatment.
Time frame: From birth or childhood into follow-up; exact duration is not established.
Anatomy, symptoms, complications, and individualized specialist management.
Complications comparison
| Complication | Presentation |
|---|---|
| Psychosocial impact | May involve distress about sex development and treatment decisions. More often relates to symptoms, procedures, or recurrence concerns. Support should be individualized; frequency is not established here. |
| Treatment burden | Hormone or surgical care may be considered; no dose or indication is specified. Removal or another intervention may be considered for selected lesions. Management decisions belong to appropriate specialists. |
| Local abdominal problems | Not an established feature of the DSD itself. Pain, obstruction, infection, or bleeding may occur, but rates are not established. Urgent abdominal symptoms need prompt clinical assessment. |
Patient education highlights
- HighDifferent conditions
One concerns sex development after androgen exposure; the other is a benign abdominal lymphatic growth.
- HighTests need interpretation
Karyotype, hormone results, and imaging are not complete diagnoses by themselves.
- MediumFollow-up questions
Ask which specialists are involved and which findings remain uncertain.